Factors influencing histological response after neoadjuvant chemoradiation therapy for rectal carcinoma
Factors influencing histological response after neoadjuvant chemoradiation therapy for rectal carcinoma
复制标题
DOI:
10.1016/j.prp.2009.04.006
复制
发表时间:
2009-01-01
影响因子:
2.8
通讯作者:
Suarez, Angel
中科院分区:
文献类型:
--
作者:
Moral, Maria;Jesus Fdez-Acenero, Ma;Suarez, Angel
Neoadjuvant chemoradiation therapy is one of the standard therapeutic regimens for rectal carcinoma. Nevertheless, chemoradiation therapy is not completely devoid of adverse effects, and it would be interesting to try to predict which patient will respond to neoadjuvancy This study aimed at analyzing factors influencing pathological response after therapy.We reviewed the clinical and morphological data of 39 patients after neoadjuvant chemoradiation therapy. We performed immunohistochemistry for p53, cyclin D1, MIB-1 (Ki67), and bcl-2 protein in paraffin-embedded tissue.In our series, 12 patients did not respond to neoadjuvant therapy, 12 showed it complete response, and 15 it partial response. There was it statistically significant association between response and cardiomyopathy (p = 0 02) and tenesmus (p = 0.02) and a trend towards significance for age (p = 0 08), preoperative TNM (P = 0.08), peritumoral inflammatory response (p = 0.07), and preoperative CEA (p = 0 08). As for immunohistochemistry, we only found it trend towards significance for cyclin D1 (p = 0 08).In our series of patients with rectal carcinoma receiving preoperative chemoradiation therapy, few factors were predictive of it histological response. The histological response seems to improve survival and reduce relapses. (C) 2009 Elsevier GmbH. All rights reserved.